Skip to content
Open access

A reproducible three-dimensional model of human brain tissue to investigate physiological and disease-associated microglia phenotypes

Aug 2026 · Nature Neuroscience · Vol 29, pp. 2324 - 2340 · 1 citation · 96 references
Medicine

TL;DR

A reproducible human three-dimensional brain tissue model with neurons, astrocytes and microglia, replicating in-vivo-like maturation and enabling the study of Alzheimer’s disease-relevant perturbations and drug responses is developed.

Abstract

Stem-cell-based in vitro models offer promising potential to elucidate human brain cell functions and interactions, but limitations in reproducibility, maturation and cell-type diversity persist. Especially, prolonged incorporation of mature microglia and studies of neuroinflammation have proven challenging. Here, we developed a human induced pluripotent stem cell-based three-dimensional cortical brain tissue model (3BTM) containing neurons, astrocytes and microglia with high reproducibility, maturity and viability. 3BTMs show morphological, functional and proteomic maturation of all cell types, leading to high similarity to their in vivo counterparts. Incorporated microglia survive for over 6 months and display mature morphology, functions and gene expression. Importantly, when engineered to model Alzheimer’s disease pathology, 3BTMs recapitulate key disease hallmarks, including amyloid deposition, increased phospho-tau levels and neuroinflammation, with microglia shifting their transcriptional landscape to disease-relevant signatures. Treatment of Alzheimer’s disease 3BTMs with anti-Aβ immunotherapy cleared deposits and largely reversed disease signatures in glia. Together, our microglia-containing model provides a platform for studying physiological and pathological states of human brain tissue. Klimmt, Cardoso Gonçalves et al. developed a reproducible human three-dimensional brain tissue model with neurons, astrocytes and microglia, replicating in-vivo-like maturation and enabling the study of Alzheimer’s disease-relevant perturbations and drug responses.

Read PDF

Similar papers

Review Open access Aug 2026

Human Stem Cell-Derived Models of the Alzheimer’s Disease Neuroimmune System

An overview of modern techniques for generating 2-dimensional monocultures and co-cultures, 3-dimensional organoids and assembloids, and chimeras containing hiPSC-derived microglia and astrocytes is provided.

Rose Summers, D. Quang, Noah R. Johnson · 0 citations
Open access Aug 2026

Development and validation of a long-term co-maturation protocol for human stem cell-derived microglia and neuronal networks

A co-maturation protocol that robustly generates glutamatergic neuronal networks containing hiPSC-derived microglia and induced the typical ramified microglia morphology and characteristic microglia-neuron interactions is presented.

A. Mordelt, I. Schuurmans, Nicky Scheefhals et al. · 0 citations
Open access Sep 2026

Human amniotic mesenchymal stromal cell-derived extracellular vesicles reprogram microglia and prevent neurodegeneration in experimental models of Alzheimer’s disease

HAMSC-EVs exert robust anti-inflammatory and neuroprotective effects in both murine and human AD models, improving cognition, modulating glial activation, and restoring synaptic integrity, and highlight the translational potential of intranasal hAMSC-EVs as an adjuvant therapeutic strategy targeting neuro inflammation...

Andrea Papait, F. Natale, A. Silini et al. · 0 citations
Review Open access Sep 2026

Human iPSC‐Derived Brain Organoids: A Disease‐Oriented Evaluation of Modeling Fidelity

This review critically evaluates the use of iPSC‐derived brain organoids as a disease‐focused approach to study neuroinflammation, neurodegeneration, infection, and aging.

Bishwa R. Pokharel, Abigail Dickerson, Sanjana G. Shenoy et al. · 0 citations
Open access Aug 2026

Plasticity of human microglia and brain perivascular macrophages in aging and Alzheimer’s disease

It is shown that a disease-associated microglial subtype, characterized by elevated GPNMB expression and enriched for polygenic AD risk, expands with AD pathology and shows increased phagocytic activity, and MITF is identified as an upstream regulator required to maintain this microglial state.

Donghoon Lee, James M. Vicari, Christian Porras et al. · 1 citation
Open access Aug 2026

DEVELOPMENT OF ORGANOID BASED MODEL TO STUDY IMMUNE-NEURAL INTERACTIONS IN HUMAN CNS DISEASES

An enhanced human induced pluripotent stem cell (hiPSC)-derived cerebral organoid (CO) platform optimized to mitigate core hypoxia for over 200 days enables longitudinal modeling of neural-immune crosstalk in age-related and neuroinflammatory CNS disorders.

J. Kocot, S. Pradhan, D. Maric et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.